McGee J O, Patrick R S, Rodger M C, Luty C M
Gut. 1974 Apr;15(4):260-7. doi: 10.1136/gut.15.4.260.
In an effort to assess connective tissue biosynthetic activity in human liver disease, collagen proline hydroxylase (a key enzyme in collagen biosynthesis) and the uptake of (35)S sulphate (a precursor of sulphated mucopolysaccharides) were measured in hepatic tissue obtained mainly by percutaneous biopsy.A procedure is described for the quantitation of collagen proline hydroxylase in cryostat sections which allows for the simultaneous histopathological examination of the liver specimen. A three to eightfold increase in the activity of this enzyme was found in four cirrhotic livers compared with the mean value of four normal livers and two biopsies from patients with Gilbert's syndrome. Elevated hydroxylase levels were found also in five patients with hepatic dysfunction but without cirrhosis (four alcoholics and one patient with persistent hepatitis associated with serum smooth muscle antibody). It is suggested that the hepatic level of collagen proline hydroxylase may be a useful quantitative index of fibroblastic activity in human liver disease. Autoradiographic studies of radioactive sulphate uptake in biopsy specimens from patients with chronic liver disease showed an exaggerated incorporation of isotope not only at sites of established fibrogenesis but also in the walls of sinusoids throughout the liver.
为了评估人类肝脏疾病中结缔组织的生物合成活性,主要通过经皮活检获取肝组织,检测其中的胶原脯氨酸羟化酶(胶原生物合成中的关键酶)以及(35)S硫酸盐(硫酸化粘多糖的前体)的摄取情况。本文描述了一种在低温切片中定量胶原脯氨酸羟化酶的方法,该方法可同时对肝脏标本进行组织病理学检查。与四个正常肝脏以及来自吉尔伯特综合征患者的两份活检标本的平均值相比,在四个肝硬化肝脏中发现该酶的活性增加了三到八倍。在五名肝功能不全但无肝硬化的患者(四名酗酒者和一名患有与血清平滑肌抗体相关的持续性肝炎的患者)中也发现羟化酶水平升高。提示胶原脯氨酸羟化酶的肝脏水平可能是人类肝脏疾病中纤维母细胞活性的一个有用的定量指标。对慢性肝病患者活检标本中放射性硫酸盐摄取的放射自显影研究表明,不仅在已形成的纤维生成部位,而且在整个肝脏的肝血窦壁中,同位素的掺入都有所增加。